CTNM – contineum therapeutics, inc. - common stock (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

CTNM

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/24

09:40 am

ctnm

Rating for CTNM

Low Report

Rating for CTNM

Report

11/24

09:40 am

ctnm

Rating for CTNM

Low Report

Rating for CTNM

Report

11/21

09:33 am

ctnm

Rating for CTNM

Low Report

Rating for CTNM

Report

11/21

09:33 am

ctnm

Rating for CTNM

Low Report

Rating for CTNM

Report

11/13

09:53 am

ctnm

Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $22.00 price target on the stock.

Medium Report

Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $22.00 price target on the stock.

Report

9/25

08:06 am

ctnm

Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $20.00 price target on the stock.

Medium Report

Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $20.00 price target on the stock.

Report

9/25

07:19 am

ctnm

Rating for CTNM

Low Report

Rating for CTNM

Report

9/25

06:06 am

ctnm

Contineum initiated with an Outperform at Leerink

Medium Report

Contineum initiated with an Outperform at Leerink

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.